Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2025 ,inter alia, to consider and approve Unaudited Standalone & Consolidated ....
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies has informed the stock exchanges that its Board of Directors will meet on Thursday, 24th July 2025. The agenda includes consideration and approval of the Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025 (Q1 FY26). The trading window for designated persons and their immediate relatives remains closed until 26th July 2025, i.e., 48 hours after the results are declared. This is a standard regulatory intimation under SEBI LODR Regulation 29.
No direct impact on shareholders or stock price from this intimation alone. Investors should watch for the Q1 results on or after 24th July for actual performance numbers that could move the stock.